DadFinStart your free week
DadFin › Stocks › Healthcare › ADUS

Addus HomeCare Corporation (ADUS) stock score

Healthcare · Medical Care Facilities · United States

$114.33 ▲ +0.06% today

86.3
Dad Score, out of 100
strong

Addus HomeCare Corporation (ADUS) is a Medical Care Facilities company in the Healthcare sector, listed in the United States. On DadFin's weekly run it scores 86.3 out of 100 on the Dad Score, a strong reading that places the business ahead of 86% of the 5,774 US and Canadian stocks DadFin fully scores. Inside Healthcare it ranks #121 of 974. Its strongest axes are valuation, quality and growth; its weakest is price action.

Scores from the run of Oct 4, 2026. The Dad Score answers one question: how good is this business, measured against its own sector. How it is built →

The eight axes

Valuation
Strong
Quality
Above average
Growth
Strong
Price action
Weak
Risk
Strong
Conviction
Above average
Liquidity
Above average
Macro
Above average

Each axis is ranked inside the stock's own sector. Subscribers see the percentile and every input behind each bar.

Key numbers

P/E (trailing)19.5×
P/E (forward)14.8×
Dividend yield0.00%
Return on capital10.9%
Operating margin9.7%
Revenue growth (YoY)+23.2%
FCF yield4.9%
Net debt / EBITDA0.06×
Piotroski F-Score7 / 9
52-week change-1.3%
Market cap$2.1B
Next earningsNov 2, 2026

What subscribers see on ADUS

Start your free weekSubscriber? Open the full research →

Medical Care Facilities peers

StockCompanyDad ScoreBandMarket cap
HCAHCA Healthcare, Inc.94.4strong$94.7B
THCTenet Healthcare Corporation85.2strong$20.8B
FMSFresenius Medical Care AG64.4middling$11.8B
EHCEncompass Health Corporation90.0strong$11.8B
DVADaVita Inc.70.5good$11.5B
UHSUniversal Health Services, Inc.96.7strong$10.4B
ENSGThe Ensign Group, Inc.78.9good$10.0B
PACSPACS Group, Inc.82.5good$6.8B

Prices from DadFin's live feed (refreshed about every 15 minutes in the session); scores from the weekly run of Oct 4, 2026. Fundamentals as reported in the latest filings. Research, not investment advice.